---
title: "Interventional Radiology"
order: 5
category: "Radiology"
---

# Interventional Radiology

## Overview

Interventional radiology (IR) is a medical subspecialty utilizing image guidance (fluoroscopy, ultrasound, CT) to perform minimally invasive diagnostic and therapeutic procedures. IR has revolutionized management of numerous conditions, offering alternatives to traditional surgery with reduced morbidity, shorter recovery, and often equivalent efficacy. Understanding common IR procedures, indications, techniques, and complications is essential for clinicians in all specialties who refer patients for interventional procedures.

### Core Principles
- **Image guidance**: Fluoroscopy, ultrasound, CT for real-time visualization
- **Minimally invasive**: Small incisions or percutaneous access
- **Multidisciplinary**: Collaboration with surgery, oncology, vascular medicine, hepatology

### Major Categories
- **Vascular interventions**: Angiography, angioplasty, stenting, embolization
- **Oncologic interventions**: Tumor ablation, chemoembolization, radioembolization
- **Non-vascular interventions**: Drainage procedures, biopsies, gastrostomy tubes

## Vascular Access and Techniques

### Seldinger Technique
**Standard method for percutaneous vascular access:**
1. **Needle**: Puncture vessel under imaging guidance
2. **Guidewire**: Thread flexible wire through needle into vessel
3. **Remove needle**: Leave wire in place
4. **Dilator/sheath**: Pass over wire to create access tract
5. **Catheter**: Exchange for working catheter

**Image guidance:**
- **Ultrasound**: Real-time vessel visualization, avoid complications
- **Fluoroscopy**: Once vascular access obtained, guide catheter advancement
- **Roadmap**: Contrast injection with fluoroscopic image hold for reference

### Common Access Sites
- **Common femoral artery**: Most common arterial access
  - Anatomic landmark: Inguinal ligament, femoral head (puncture over medial head)
  - Complications: Retroperitoneal hemorrhage (too high), pseudoaneurysm, AV fistula, thrombosis
- **Radial artery**: Transradial access
  - Advantages: Ambulate immediately, lower bleeding risk
  - Allen test: Ensure ulnar collateral blood flow
- **Internal jugular vein**: Central venous access
- **Femoral vein**: Venous procedures

### Closure Devices
- **Manual compression**: Standard, 15-20 minutes for arterial
- **Closure devices**: Collagen plug, suture-mediated, reduce time to hemostasis

## Diagnostic Angiography

### Indications
- **Arterial disease**: Stenosis, occlusion, aneurysm evaluation
- **Bleeding**: GI bleeding (angiography +/- embolization), trauma
- **Tumor vascularity**: Pre-surgical embolization
- **Vascular mapping**: Pre-transplant, pre-surgery

### Technique
1. **Vascular access**: Usually femoral artery
2. **Catheter selection**: Various shapes to select target vessel (e.g., Cobra, SOS, Simmons for visceral vessels)
3. **Contrast injection**: Iodinated contrast under fluoroscopy
4. **Digital subtraction angiography (DSA)**: Subtract pre-contrast from post-contrast images, isolate vessels

### Complications
- **Access site**: Bleeding, hematoma, pseudoaneurysm, AV fistula, thrombosis, dissection
- **Contrast**: Allergic reaction, contrast-induced nephropathy
- **Embolic**: Cholesterol emboli, thromboembolic events
- **Vascular injury**: Dissection, perforation, spasm

## Peripheral Arterial Disease Interventions

### Peripheral Angioplasty and Stenting

#### Indications
- **Claudication**: Lifestyle-limiting symptoms
- **Critical limb ischemia**: Rest pain, tissue loss (ulcers, gangrene)
- **ABI**: <0.9 diagnostic, <0.4 critical ischemia

#### Technique
1. **Diagnostic angiogram**: Define anatomy, lesions
2. **Cross lesion**: Wire across stenosis/occlusion
3. **Balloon angioplasty**: Inflate balloon to dilate stenosis
4. **Stenting**: If inadequate angioplasty result (recoil, dissection, residual stenosis >30%)

#### Lesions
- **Aortoiliac**: Good results, often stented
- **Femoral-popliteal**: More challenging, higher restenosis
- **Below-knee**: Complex, often multivessel disease, lower patency

#### Outcomes
- **Technical success**: >95%
- **Patency**: Variable by location (iliac best, below-knee worst), drug-eluting technologies improving
- **Restenosis**: Neointimal hyperplasia, may require re-intervention

### Renal Artery Stenosis

#### Indications (CONTROVERSIAL)
- **Atherosclerotic RAS**: Medical management often preferred (CORAL, ASTRAL trials showed minimal benefit)
- **Possible indications**: Resistant hypertension, flash pulmonary edema, progressive renal dysfunction
- **Fibromuscular dysplasia**: Angioplasty very effective, young women, "string of beads"

#### Technique
- **Angioplasty ± stenting**: Atherosclerotic often requires stent, FMD usually angioplasty alone

### Carotid Artery Stenting

#### Indications
- **High surgical risk**: Cardiac disease, contralateral occlusion, re-stenosis post-CEA, radiation-induced stenosis
- **Symptomatic stenosis**: >50% with stroke/TIA
- **Asymptomatic**: >80% (controversial)

#### Technique
- **Femoral access**: Guide catheter to carotid
- **Embolic protection device**: Filter or flow reversal to prevent distal embolization
- **Predilation**: Often needed
- **Stent deployment**: Self-expanding stent
- **Post-dilation**: Optimize stent apposition

#### Complications
- **Stroke**: 2-6% (similar to CEA)
- **Bradycardia/hypotension**: Baroreceptor stimulation during angioplasty
- **Access site complications**

#### Comparison to CEA
- **CREST trial**: Similar outcomes for symptomatic patients
- **Slight increase in periprocedural stroke** with stenting vs CEA
- **Slight increase in MI** with CEA vs stenting

## Hemorrhage Control

### GI Bleeding Embolization

#### Indications
- **Active bleeding**: Demonstrated on angiography, endoscopy/colonoscopy failed or not feasible
- **Hemodynamic instability**: Despite resuscitation
- **Recurrent bleeding**: After initial endoscopic management

#### Technique
1. **Diagnostic angiography**: Identify bleeding source (contrast extravasation)
  - **Upper GI**: Celiac, SMA
  - **Lower GI**: SMA, IMA
2. **Selective catheterization**: Engage vessel feeding bleeding site
3. **Embolization**:
  - **Temporary agents**: Gelfoam (resorbs in weeks)
  - **Permanent agents**: Coils, particles, glue
  - **Choice**: Balance hemostasis vs ischemia risk

#### Success and Complications
- **Technical success**: 90-100%
- **Clinical success**: 70-90% (some re-bleed)
- **Ischemia/infarction**: <10% (colon at higher risk due to limited collaterals)

### Trauma Embolization

#### Indications
- **Solid organ injury**: Liver, spleen, kidney with active bleeding on CT
- **Pelvic fracture**: Significant hemorrhage
- **Hemodynamically stable**: Or stabilized with resuscitation

#### Technique
- **Selective embolization**: Target bleeding vessel
- **Spleen**: Try to preserve spleen (selective vs proximal embolization)
- **Liver**: Segmental embolization
- **Pelvis**: Internal iliac artery branches

#### Advantages
- **Organ salvage**: Avoid splenectomy, nephrectomy
- **Avoid surgery**: In unstable patient
- **High success**: 80-95%

### Bronchial Artery Embolization

#### Indications
- **Massive hemoptysis**: >200-300 mL/24 hours
- **Recurrent hemoptysis**: Despite medical therapy
- **Pre-surgical**: Temporize before definitive surgery

#### Technique
- **Bronchial artery** origin from descending thoracic aorta (T5-T6)
- **Selective catheterization**: Small, tortuous vessels
- **Particles or coils**: Embolize distal to spinal artery origin (avoid spinal ischemia)

#### Complications
- **Spinal cord ischemia**: Rare but devastating (anterior spinal artery may arise from bronchial artery)
- **Chest pain**: Transient
- **Recurrence**: 20-40% (may need repeat)

### Uterine Artery Embolization

#### Indications
- **Uterine fibroids**: Symptomatic (menorrhagia, bulk symptoms), desire uterine preservation
- **Adenomyosis**: Less responsive than fibroids
- **Post-partum hemorrhage**: Life-saving

#### Technique
- **Bilateral uterine arteries**: Catheterize and embolize
- **Particles**: Permanent embolic agents (PVA, tris-acryl)
- **Endpoint**: Sluggish flow, pruning of vessels

#### Outcomes
- **Symptom improvement**: 85-90% at 1 year
- **Fibroid shrinkage**: 40-60% volume reduction
- **Re-intervention**: 20-30% at 5 years

#### Complications
- **Post-embolization syndrome**: Pain, fever, nausea (common, self-limited, 1-2 weeks)
- **Infection**: 1-2%, may require hysterectomy
- **Ovarian failure**: 1-2%, age-dependent risk
- **Non-target embolization**: Ovaries (if anastomoses)

## Venous Interventions

### Deep Vein Thrombosis Treatment

#### Catheter-Directed Thrombolysis (CDT)
**Indications:**
- **Acute DVT** (<14 days)
- **Symptomatic** (leg swelling, pain)
- **Iliofemoral DVT** (higher benefit than calf DVT)
- **Low bleeding risk**
- **Young, active patients** (reduce post-thrombotic syndrome)

**Technique:**
- **Venous access**: Popliteal or pedal vein
- **Catheter placement**: Into thrombus
- **Thrombolytic infusion**: tPA through catheter (overnight, 12-24 hours)
- **Adjunctive angioplasty/stenting**: If underlying stenosis (May-Thurner syndrome)

**Outcomes:**
- **Reduced post-thrombotic syndrome**: Compared to anticoagulation alone
- **Bleeding risk**: 10-15% (most minor)

#### Mechanical Thrombectomy
- **AngioJet, Aspirex** devices
- **Adjunct to CDT** or standalone
- **Faster** than CDT alone

### Inferior Vena Cava (IVC) Filter

#### Indications
- **Contraindication to anticoagulation**: Active bleeding, recent surgery, high fall risk
- **Failure of anticoagulation**: Recurrent PE despite therapeutic anticoagulation
- **Prophylactic**: Controversial (trauma, high-risk surgery)

#### Types
- **Retrievable**: Intended for temporary placement (weeks to months), but many become permanent
- **Permanent**: Older designs, not retrievable

#### Technique
- **Femoral or jugular vein** access
- **Infra-renal IVC**: Below renal veins (prevent renal vein thrombosis)
- **Deployment**: Spring-loaded or self-expanding

#### Complications
- **Filter thrombosis**: IVC occlusion
- **Filter migration**: Embolization to heart
- **Perforation**: Through IVC wall
- **Recurrent PE**: 2-5% (some pass through or around filter)
- **Retrieval**: Recommended when anticoagulation safe, but <50% actually retrieved

### Transjugular Intrahepatic Portosystemic Shunt (TIPS)

#### Indications
- **Variceal bleeding**: Refractory to medical/endoscopic therapy
- **Refractory ascites**: Despite diuretics and sodium restriction
- **Hepatic hydrothorax**: Pleural effusion from ascites
- **Budd-Chiari syndrome**: Hepatic vein thrombosis

#### Technique
1. **Jugular access**: Right internal jugular vein
2. **Hepatic vein catheterization**: Usually right hepatic vein
3. **Portal vein puncture**: Needle through hepatic parenchyma into portal vein (blind, ultrasound, or wedged hepatic venogram guidance)
4. **Tract dilation**: Balloon angioplasty
5. **Stent placement**: Covered stent from hepatic to portal vein

#### Effects
- **Decompresses portal system**: Reduce portal hypertension
- **Portosystemic shunt**: Portal blood bypasses liver → systemic circulation

#### Outcomes
- **Variceal bleeding**: Effective control
- **Ascites**: Improvement in 60-80%
- **Stenosis**: 20-30% at 1 year with bare-metal stents, <10% with covered stents
- **Require surveillance**: Ultrasound every 6-12 months

#### Complications
- **Hepatic encephalopathy**: 20-40% (ammonia bypass liver)
- **Liver failure**: Worsening hepatic function (blood bypasses liver)
- **Bleeding**: Intraperitoneal, hemobilia
- **Stenosis/occlusion**: Requiring re-intervention

#### Contraindications
- **Relative**: Heart failure (increased preload), severe hepatic failure, hepatic encephalopathy
- **Absolute**: Polycystic liver disease, severe pulmonary hypertension

## Oncologic Interventions

### Tumor Ablation

#### Radiofrequency Ablation (RFA)
**Mechanism:**
- **Alternating current**: Creates heat, coagulative necrosis
- **Probe placement**: Percutaneous (CT or ultrasound guidance)
- **Temperature**: 60-100°C

**Indications:**
- **Liver tumors**: HCC (<3 cm), metastases (colorectal, limited)
- **Lung tumors**: Small (<3 cm) primary or metastatic
- **Kidney tumors**: Small RCC (<4 cm), non-surgical candidates
- **Bone metastases**: Pain palliation

**Outcomes:**
- **Small HCC** (<3 cm): Similar to surgical resection
- **Colorectal liver metastases**: Limited disease, complete response possible

**Complications:**
- **Bleeding, infection**: <5%
- **Adjacent organ injury**: Colon, diaphragm perforation
- **Pneumothorax**: Lung RFA
- **Skin burns**: Grounding pad

#### Microwave Ablation (MWA)
- **Similar to RFA**: Heat-based ablation
- **Advantages**: Higher temperatures, faster, less affected by heat sink (vessels)
- **Increasingly preferred** over RFA

#### Cryoablation
- **Freeze tissue**: Argon gas, -40°C
- **Ice ball formation**: Visible on CT (helps monitor)
- **Kidney tumors**: Often preferred (easier to monitor, less pain)
- **Lung**: Alternative to RFA

### Transarterial Chemoembolization (TACE)

#### Indications
- **Hepatocellular carcinoma**: Unresectable, preserved liver function (Child A/B)
- **Barcelona Clinic Liver Cancer (BCLC) intermediate stage** (Stage B)

#### Technique
1. **Hepatic angiography**: Map arterial supply to tumor
2. **Selective catheterization**: Tumor-feeding artery
3. **Chemotherapy infusion**: Doxorubicin, cisplatin (mixed with lipiodol)
4. **Embolization**: Particles or gelfoam to occlude artery

**Mechanism:**
- **Dual effect**: Chemotherapy + ischemia
- **HCC** is hypervascular, primarily arterial supply; normal liver has dual (arterial + portal)

**Outcomes:**
- **Tumor response**: 50-70%
- **Survival**: Median 20-30 months (vs 16 months untreated)
- **Repeated treatments**: Often necessary

**Complications:**
- **Post-embolization syndrome**: Pain, fever, nausea (near-universal, self-limited)
- **Liver failure**: If excessive embolization or poor baseline function
- **Abscess**: <5%, higher if biliary obstruction

#### Drug-Eluting Beads TACE (DEB-TACE)
- **Beads loaded with doxorubicin**
- **Sustained drug release**: Reduce systemic exposure
- **Similar efficacy**, possibly fewer systemic side effects

### Transarterial Radioembolization (TARE, Y-90)

#### Mechanism
- **Yttrium-90 microspheres**: Beta radiation emitters
- **Infuse into hepatic artery**: Preferentially lodge in hypervascular tumor
- **Local radiation**: 150 Gy to tumor, spare normal liver

#### Indications
- **HCC**: Similar to TACE
- **Colorectal liver metastases**: Unresectable, chemotherapy-refractory
- **Neuroendocrine liver metastases**

#### Advantages over TACE
- **Single treatment** (vs multiple TACE)
- **Less post-embolization syndrome**
- **Portal vein thrombosis**: Not a contraindication (can treat)

#### Pre-treatment
- **Hepatopulmonary shunt study**: Tc-99m MAA scan (assess lung shunt fraction)
- **Coil embolization**: Gastroduodenal, right gastric arteries (prevent non-target embolization → GI ulceration)

#### Complications
- **Radiation pneumonitis**: If high lung shunt (>20%)
- **GI ulceration**: Non-target embolization
- **Liver failure**: Excessive radiation to normal liver

## Non-Vascular Interventions

### Image-Guided Biopsy

#### Indications
- **Tissue diagnosis**: Masses, lymph nodes
- **Staging**: Confirm metastatic disease
- **Infection**: Culture

#### Technique
- **Imaging**: CT, ultrasound, fluoroscopy
- **Needle types**:
  - **Fine needle aspiration (FNA)**: 20-25 gauge, cytology
  - **Core biopsy**: 14-20 gauge, histology (preferred for most applications)
  - **Vacuum-assisted**: Larger samples
- **Coaxial technique**: Place larger guide needle, multiple samples through guide

#### Sites
- **Lung**: Pneumothorax 20-30% (chest tube <10%)
- **Liver**: Low bleeding risk
- **Kidney**: Hematuria common, serious bleeding rare
- **Bone**: Osteolytic or blastic lesions
- **Lymph nodes**: Palpable or deep

#### Complications
- **Bleeding**: Depends on site, vascular lesions higher risk
- **Infection**: Rare
- **Pneumothorax**: Lung biopsies
- **Tumor seeding**: Rare

### Abscess and Fluid Collection Drainage

#### Indications
- **Abscesses**: Intra-abdominal, pelvic, hepatic, splenic, psoas
- **Symptomatic fluid collections**: Post-surgical, pancreatitis

#### Technique
1. **Imaging**: CT or ultrasound guidance
2. **Access**: Percutaneous needle, then catheter (Seldinger or trocar)
3. **Drain placement**: 8-14 French catheter, secure to skin
4. **Drainage**: Gravity or suction
5. **Irrigation**: Saline flushes if thick

#### Management
- **Antibiotics**: Systemic coverage
- **Monitor output**: Decreasing volume indicates resolution
- **Follow-up imaging**: CT to assess cavity size
- **Removal**: When output minimal and cavity resolved

#### Success
- **80-90%** for unilocular abscesses
- **Lower** for multiloculated, thick-walled, or fungal

#### Complications
- **Sepsis**: From manipulation
- **Bleeding**: Vascular injury
- **Perforation**: Bowel or other organs

### Percutaneous Gastrostomy and Gastrojejunostomy

#### Indications
- **Enteral nutrition**: Long-term (>4-6 weeks)
- **Unable to swallow safely**: Stroke, neurodegenerative diseases, head/neck cancer
- **Bowel rest**: Gastrojejunostomy for pancreatitis, gastroparesis

#### Techniques
- **Push** (per-oral): Endoscopy, pull string through
- **Pull**: Endoscopy-guided PEG (most common)
- **Image-guided (IR)**: Fluoroscopy and/or ultrasound (if endoscopy not feasible)

#### Complications
- **Infection**: Wound, peritonitis
- **Bleeding**: Gastric vessel injury
- **Tube dislodgement**: Replace promptly if tract mature (>3-4 weeks)
- **Buried bumper syndrome**: Internal bumper erodes into gastric wall

## Venous Access Devices

### Types
- **PICC** (Peripherally Inserted Central Catheter): Basilic/cephalic vein to SVC
- **Tunneled catheter** (Hickman, Groshong): Subcutaneous tunnel, cuff
- **Implanted port** (Port-a-Cath): Subcutaneous reservoir

### Indications
- **Long-term IV access**: Chemotherapy, TPN, antibiotics
- **Difficult peripheral access**
- **Hemodialysis**: Tunneled dialysis catheters

### Complications
- **Infection**: Line-associated bloodstream infection (CLABSI)
- **Thrombosis**: Catheter-associated DVT
- **Malposition**: Tip in wrong location
- **Pneumothorax**: Internal jugular/subclavian access

## Summary

Interventional radiology provides minimally invasive image-guided therapies across diverse clinical scenarios. Vascular interventions include peripheral arterial disease angioplasty/stenting for claudication and critical limb ischemia, carotid stenting as alternative to endarterectomy, and embolization for hemorrhage control (GI bleeding, trauma, hemoptysis, uterine fibroids). Venous interventions encompass catheter-directed thrombolysis for DVT, IVC filter placement when anticoagulation contraindicated, and TIPS for portal hypertension complications. Oncologic interventions offer tumor ablation (RFA, microwave, cryoablation) for liver, lung, and kidney tumors, and transarterial therapies (TACE, Y-90) for unresectable hepatocellular carcinoma and liver metastases. Non-vascular procedures include image-guided biopsies for tissue diagnosis, abscess drainage as alternative to surgery, and placement of feeding tubes and long-term venous access devices. Understanding IR capabilities, appropriate patient selection, and potential complications enables clinicians to leverage these powerful tools in multidisciplinary patient management, often avoiding more invasive surgical approaches while achieving equivalent therapeutic outcomes.
